Bioactive Agent Monitoring via Artificial Sensory Experience
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack an effective integration of bioactive agents with artificial sensory experiences to monitor and manage their desired effects on individuals, particularly in a systematic and technology-driven manner.
Innovation Solution
A system and method that accepts indications of bioactive agent use and assigns artificial sensory experiences to monitor their effects, utilizing circuitry and programming to combine prescription medications with virtual or real-world sensory stimuli, allowing for personalized treatment combinations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If bioactive agents are used to treat individuals, then therapeutic effects are achieved, but there is a lack of systematic monitoring and management of their desired effects
Solution Approach 1:
The patent combines bioactive agent administration with artificial sensory experience delivery into a single integrated system. The system simultaneously administers prescription medications and provides virtual or augmented reality sensory stimuli, allowing coordinated delivery of multiple therapeutic modalities that reinforce each other's effects
Solution Approach 2:
The system incorporates monitoring capabilities that track the effects of bioactive agents on individuals in real-time. This feedback mechanism allows the system to adjust and optimize treatment parameters based on measured outcomes, thereby systematically managing therapeutic effectiveness
2Measurement precision
If artificial sensory experiences are assigned to monitor bioactive agent effects, then treatment monitoring capability is enhanced, but integration complexity increases
Solution Approach 1:
The system is designed to handle multiple types of bioactive agents and multiple types of artificial sensory experiences through a single unified platform. The system can administer various prescription medications while simultaneously delivering different forms of sensory stimuli including virtual reality, augmented reality, and other immersive experiences through a common interface and control mechanism
Solution Approach 2:
The patent employs an intermediary computing system that acts as a mediator between the bioactive agent administration and the artificial sensory experience delivery. This intermediary coordinates the timing, dosage, and intensity of both modalities, simplifying the integration complexity by providing a centralized control layer that manages the interactions between different therapeutic components
3Productivity
If personalized treatment combinations are provided, then treatment efficacy is enhanced, but system complexity and customization requirements increase
Solution Approach 1:
The system is designed to dynamically adjust treatment parameters based on individual patient responses and real-time monitoring data. The artificial sensory experiences and bioactive agent dosages can be modified on-the-fly to optimize therapeutic outcomes for each individual, transforming a static treatment protocol into an adaptive, responsive system
Solution Approach 2:
The system enables customization of treatment by allowing modification of various parameters including the type and intensity of artificial sensory experiences, dosage and timing of bioactive agents, and duration of treatment sessions. These parameter changes can be tailored to individual patient needs while being managed through the system's integrated control interface
Data Source
AI summary
Methods, computer program products, and systems are described that include accepting at least one indication of a bioactive agent use by an individual and/or assigning an artificial sensory experience to monitor at least one desired effect of the bioactive agent on the individual.